Oncosil appoints ex-Cochlear boss as director

Company News

Oncosil Medical (ASX:OSL) says its pleased to announce the appointment of Dr Chris Roberts as an independent non-executive director of the company, effective immediately.
 
Dr Roberts was most recently the Chief Executive Officer and President of Cochlear (ASX:COH) until August last year, and has more than 40 years experience in the medical innovation space.
 
Cochlear is the global market leader in implantable devices and Dr Roberts was primarily responsible for the significant increase in Cochlear’s sales from $348 million in 2005 to $926 million in 2015. 
 
Dr Roberts was also previously chairman of Sirtex Limited (ASX:SRX) and executive vice-president of Resmed Inc (ASX:RMD).
 
Oncosil reported a net loss of $2.88 million at 30 June 2015. 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?